Genomics and systems biology in malaria drug discovery

Dharia, N.V.; Chatterjee, A.; Winzeler, E.A.

Current Opinion in Investigational Drugs 11(2): 131-138

2010


ISSN/ISBN: 1472-4472
PMID: 20112162
Document Number: 644441
A disadvantage of using target-based drug discovery in the search for new antimalarials is that predicting which targets will be essential for parasite growth in mammalian hosts is often difficult. In addition, well-validated targets may not yield new classes of compounds. Finally, resistance may emerge more quickly for compounds that interact with a single cellular target.

Document emailed within 1 workday
Secure & encrypted payments